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Pancreatic cancer is the eighth leading cause of cancer-related deaths in Taiwan. Pancreatic cancer has a
poor prognosis. Diagnosis of early-stage pancreatic cancer, which can be deﬁned based on resectability,
size, or curability, will improve survival. Diagnostic tools for pancreatic cancer include transabdominal
ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), endoscopic retrograde
cholangiopancreatography (ERCP), and endoscopic ultrasound (EUS). We report the case of a 48-year-old
man who presented with progressively yellowing skin. An CT imaging study did not reveal the pancreatic
lesion. Further imaging with EUS was performed to search for the organic lesion causing an abrupt distal
common bile duct stricture, and a heterogeneous hypoechoic tumor located at the uncinate process was
identiﬁed. The patient underwent a Whipple operation because malignancy could not be ruled out. The
ﬁnal pathological result was moderate to poorly differentiated adenocarcinoma.
Copyright © 2016, The Chinese Oncology Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pancreatic cancer has been the eighth leading cause of cancer-
related deaths in Taiwan in recent years. In most cases, the
outcome of pancreatic cancer is poor.1 The clinical manifestations of
pancreatic tumors are epigastralgia, jaundice, steatorrhea, body
weight loss, vomiting, anorexia, and asthenia. Initial clinical pre-
sentations, such as painless jaundice and new onset diabetes, may
be early signs of a pancreatic head tumor.2e4
Diagnostic tools for pancreatic cancer include transabdominal
ultrasonography, computed tomography (CT), magnetic resonance
imaging (MRI), endoscopic retrograde cholangiopancreatography
(ERCP), and endoscopic ultrasound (EUS).5e7 In recent years, im-
provements in the imaging technologies mentioned above have
helped in the early detection of pancreatic cancer. The high sensi-
tivity and speciﬁcity of EUS plays an important role when trying toogy, Department of Internal
hung-Shan North Road, Taipei
ncology Society.
Society. Production and hosting byidentify a small pancreatic tumor. It also helps in obtaining tissue
samples via ﬁne needle aspiration.5,6
In this case, the initial CT image did not reveal the pancre-
atic head tumor. We share our experience of using EUS for
detection of a small pancreatic head tumor. We conﬁrmed the
diagnosis of pancreatic head adenocarcinoma after surgical
intervention.
2. Case report
A 48-year-old man had a medical history of hypertension and
diabetes mellitus controlled with an oral hypoglycemic agent
combined with insulin for 2 years. He developed progressively
yellowing skin over the course of 1 week. He complained of post-
prandial abdominal fullness with dull pain, tea colored urine, and
diarrhea with light bright oil muddy stool in the last week. He
denied the presence of fever, clay-colored stool, and recent body
weight loss.
Biochemistry data revealed hyperbilirubinemia (total bilirubin
level: 13 mg/dL, direct bilirubin level: 8.0 mg/dL), elevated alkaline
phosphate (ALK-P: 688 IU/L) level, elevated r-glutamyl trans-
peptidase (r-GT: 1842 IU/L) level, and an abnormal liver function
test (aspartate transaminase [AST] level: 230 IU/L, alanineElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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tested negative for hepatitis B and hepatitis C. Echography showed
a gallbladder (GB) stone and common bile duct (CBD) dilatation.
Conventional abdominal CT with and without contrast also
conﬁrmed the presence of GB stones and CBD dilatation. It did not
reveal any abnormal pancreatic head lesion (Fig. 1).
Endoscopic retrograde cholangiopancreatography (ERCP) was
performed under the indication of obstructive jaundice. The ﬂuo-
roscopy showed proximal CBD dilatation with an abrupt distal CBD
stricture. One plastic stent (8.5 Fr, 9 cm) was placed in the distal
CBD (Fig. 2A). A biopsy was obtained from the edematous change of
the papilla with villous appearance (Fig. 2B). The ﬁnal pathological
result was chronic inﬂammation.
The patient's serum tumor marker levels were as follows: car-
cinoembryonic antigen (CEA) 1.71 ng/mL (normal range < 5.00 ng/
mL) and CA 19-9 283.90 U/mL (normal range < 37.00 U/mL). The
immunoglobulin subclass 4 level was within the normal range.
Because of high suspicion of malignancy, we chose endoscopic
ultrasound (EUS) instead of MRI of the pancreas to detect the
organic lesion that caused the distal CBD stricture because initial
abdominal CT did not show any suspicious lesion in the pancreas. In
addition, tissue sample could be obtained using EUS ﬁne needle
aspiration if any suspicious lesions are found. EUS revealed
pancreatic duct dilatation in the head portion and one heteroge-
neous hypoechoic tumor of about 2.68  2.34 cm located at the
uncinate process (Fig. 3). Fine needle aspiration from the uncinate
process tumor was performed. The ﬁnal cytology report showed
negative results for malignancy.
MRI was performed to view the irregular enhanced lesion at the
uncinate process of the pancreas on the arterial phase. Diffusion
weighted images also showed relatively high signal intensity in the
uncinate process (Fig. 4). A high malignancy potential of the
pancreatic uncinate process was suspected from the imaging
results.
We performed a Whipple operation with ﬁndings of a hard
pancreatic tumor, which compressed to the distal CBD with dila-
tation. On gross appearance, it was a circumferential sclerotic tu-
mor, measuring 2.5  2.5  1.5 cm in size, involving the pancreatic
head. The margins of the peripancreatic tissue were free of tumor.
Microscopically, vascular invasionwas absent. Two out of 21 lymph
nodes showed metastatic adenocarcinoma. It was proven to be a
moderately to poorly differentiated pancreatic head adenocarci-
noma (Fig. 5). According to the American Joint Committee on
Cancer 7th Edition Staging, the pathologic TNM stage was T2N1M0,
Stage IIB. After surgical intervention, the patient received systemic
chemotherapy with gemcitabine.Fig. 1. (A) Pre-contrast phase of abdominal CT showed one GB stone (Arrow). (B) Post-contr
(Arrow).3. Discussion
Pancreatic cancer is the eighth leading cause of cancer-related
deaths in Taiwan.1 The most common initial clinical presentation
of pancreatic exocrine tumors is pain, jaundice, and weight loss.2
The initial clinical presentation depends on the location of the
pancreatic tumor. Jaundice, steatorrhea, and weight loss are more
common symptoms in patients with pancreatic head tumors
compared with in those with tumors in the body or tail.2e4 Around
60 to 70 percent of exocrine pancreatic cancers are located in the
head portion of the pancreas, while only 20 to 25 percent are found
in the body or tail.8 Pancreatic head tumors with an initial pre-
sentation of painless jaundice tend to have a more favorable
prognosis, making surgical intervention desirable.3,9 The present
patient had a medical history of diabetes mellitus diagnosed less
than 2 years ago. New onset diabetes mellitus can be an early sign
of pancreatic head adenocarcinoma.10
Transabdominal ultrasonography is the ﬁrst-line imaging study
used in patients with suspected biliary obstruction of unknown
etiology.11 Transabdominal ultrasonography is readily available,
inexpensive, and does not use ionizing radiation. However, it is not
a suitable screening tool for detection of pancreatic masses due to
its relatively low sensitivity. A pancreatic carcinoma typically ap-
pears as a focal hypoechoic hypovascular solid mass with irregular
margins.12 In one study, the sensitivity for detection of pancreatic
masses has been reported to range from 67 to 90% because of high
operator dependence.13
Multi-detector computed tomography (MDCT) is widely avail-
able and is the best-validated imaging modality for the evaluation
of a patient with a suspected pancreatic mass. The typical image of
pancreatic adenocarcinoma on MDCT is an ill-deﬁned hypo-
enhancing mass.12 The sensitivity of MDCT for the detection of
pancreatic adenocarcinoma is as high as 89e97%.14 However, the
shortcoming of MDCT is its low sensitivity for small lesions (less
than 1.5 cm) of pancreatic tumors. The detection rate of small le-
sions in pancreatic head by MDCT is only 67% in this study.15 In
another study, the sensitivity was 100% for tumors >2 cm, but only
77% for tumors 2 cm in size.16 In the present case, the initial
abdominal CT did not reveal the primary tumor in the pancreatic
head, perhaps because of its size.
In an early meta-analysis, diagnosing cancer of the pancreas by
ERCP with the “double duct” sign had a sensitivity of 92% and
speciﬁcity of 96%.17 In the present case, mild proximal CBD dilata-
tion with an abrupt distal CBD stricture was detected by ERCP. The
most common malignant cause of obstructive jaundice in middle-
aged adults in North America is cancers of the pancreatobiliaryast phase of abdominal CT revealed mild CBD dilatation without pancreatic head lesion
Fig. 2. (A) Endoscopic retrograde cholangiopancreatography showed proximal CBD dilatation with distal CBD stricture (Arrow). (B) Edematous change with villous appearance of
papilla is detected by side view endoscope (Arrow).
Fig. 3. (A) The CBD is measured about 3.9 mm with stent in situ (Arrow). (B) One heterogeneous hypoechoic tumor about 2.68  2.34 cm located at uncinate process (Arrow).
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organic cause of abrupt distal CBD disruption.
EUS provides better image resolution compared with trans-
abdominal ultrasonography because of the small distance between
the echoendoscope and the pancreas through the gastric or
duodenal wall. It also helps in obtaining tissue samples fromFig. 4. Axial arterial-phase gadolinium-enhanced T1-weighted fat-suppressed
gradient recalled echo MR image showed central hypointensity irregular mass with
peripheral enhancement in uncinate process of pancreas (Small arrow). P: Pancreatic
head (Large arrow), C: Common bile duct (Middle arrow) A: Superior mesentery artery,
V: Superior mesentery vein.suspicious lesions via EUS guided ﬁne needle aspiration (EUS-FNA).
In one meta-analysis, the sensitivity of EUS-FNA for pancreatic
cancer was 92% and the speciﬁcity was 96%.19 In a previous imaging
study, for diagnosis of pancreatic cancer less than 10mm in size and
pancreatic duct dilatation, the tumor detection rate was higher on
EUS than on CT or other modalities, and EUS-guided ﬁne needle
aspiration was helpful in conﬁrming the histologic diagnosis.5,6Fig. 5. Microscopic photo showing moderate to poorly differentiated invasive adeno-
carcinoma with marked desmoplastic stromal reaction. Tumor cell nuclei are hyper-
chromatic with nuclear pleomorphism. (Arrow, H&E stain, magniﬁcation 40).
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pancreatic cancer. It has become widely used in the diagnosis of
pancreatic pathologies because of its very high soft-tissue contrast
resolution, with an accuracy in the detection and staging of
adenocarcinoma of 90e100%. MR cholangiopancreatography also
provides images of pancreatic ductal system abnormalities.
Furthermore, diffusion-weighted imaging (DWI) may provide
further information about a wide variety of solid and cystic lesions
of the pancreas and enable detection of solid pancreatic tumors
with a high cellularity or ﬁbrosis.7
In conclusion, diabetes mellitus diagnosed less than 2 years
prior was suggestive of an early sign of pancreatic head adenocar-
cinoma. However, the sensitivity of abdominal CT for detecting
pancreatic head tumors smaller than 2 cm is low. MRI of the
pancreas is another alternative to view detailed images of pancre-
atic anatomy. Moreover, it has a higher sensitivity for pancreatic
tumors, but it does not enable tissue sampling. In the present case,
the beneﬁt of EUS is that not only does it provide us with a high
detection rate for small lesions of the pancreatic head tumor but
also enables tissue sampling via FNA. Although FNAwas negative in
this patient, EUS and MRI were both important to evaluate possible
pancreatic tumors.
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